KALA stock forecast
Our latest prediction for Kala Pharmaceuticals, Inc.'s stock price was made on the March 13, 2020 when the stock price was at 6.48$.
In the short term (2weeks), KALA's stock price should underperform the market by -0.48%. During that period the price should oscillate between -10.95% and +14.51%.
In the medium term (3months), KALA's stock price should underperform the market by -1.87%. During that period the price should oscillate between -36.67% and +30.08%.Get email alerts
Create a solid portfolio with KALA
About Kala Pharmaceuticals, Inc.
Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.
At the moment the company generates 6M USD in revenues.
On its last earning announcement, the company reported a loss of -2.76$ per share.
The book value per share is 2.77$
Three months stock forecastMarch 13, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|